Home › Steatotic Liver Disease › Louisiana › Lafayette
Steatotic Liver Disease clinical trials in Lafayette, LA
3 studies for Steatotic Liver Disease are looking for participants at sites in and around Lafayette (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RecruitingPhase 3
- 89bio Clinical Study Site, Lafayette
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RecruitingPhase 3
- Care Access - New Iberia, New Iberia · 19 mi away
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RecruitingPhase 3
- Akero Clinical Study Site, Lafayette
About Steatotic Liver Disease
Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.
More about Steatotic Liver Disease on MedlinePlus
Steatotic Liver Disease trials in other cities
- San Antonio, TX17 studies
- Miami, FL16 studies
- New York City, NY16 studies
- San Diego, CA14 studies
- Houston, TX13 studies
- Austin, TX13 studies
- Richmond, VA12 studies
- Tucson, AZ10 studies
- Chandler, AZ10 studies
- Orlando, FL9 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
Other studies in Lafayette
- Crohn's Disease7 studies
- Ulcerative Colitis5 studies
- Obesity4 studies
- Overweight3 studies
- Heart Failure3 studies
- Non-Muscle Invasive Bladder Cancer3 studies
- Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.